Company Filing History:
Years Active: 2007
Title: Bireshwar Mukherjee: Innovator in Pharmaceutical Chemistry
Introduction
Bireshwar Mukherjee is a prominent inventor based in West Bengal, India, known for his significant contribution to pharmaceutical chemistry. His research primarily focuses on developing compounds that target muscarinic receptors, which play a crucial role in various physiological processes within the body.
Latest Patents
Bireshwar holds a notable patent for “3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists.” This innovative invention pertains to derivatives of 3,6-disubstituted azabicyclo compounds that serve as muscarinic receptor antagonists. These compounds are particularly promising for the treatment of several diseases affecting the respiratory, urinary, and gastrointestinal systems, as they effectively mediate through muscarinic receptors. Moreover, the patent details pharmaceutical compositions that comprise these novel compounds and provides methods to treat ailments mediated through muscarinic receptors.
Career Highlights
Bireshwar currently works at Ranbaxy Laboratories, Inc., a significant player in the pharmaceutical industry. His expertise and dedication to research have led him to develop groundbreaking innovations, further establishing his reputation as a leader in his field. With a keen focus on enhancing therapeutic strategies, Bireshwar is committed to contributing to advancements in medical science through his inventive work.
Collaborations
Throughout his career, Bireshwar has collaborated with distinguished colleagues, including Anita Mehta and Arundutt Viswanatham Silamkoti. These collaborations foster a dynamic environment for innovative thinking and research, allowing for the development of impactful pharmaceutical solutions.
Conclusion
Bireshwar Mukherjee's contributions to the field of pharmaceutical chemistry and his innovative work on muscarinic receptor antagonists mark him as a notable figure in the realm of inventions. With his patent and collaborations within Ranbaxy Laboratories, he continues to push the boundaries of medical research, ultimately benefiting patients and healthcare systems worldwide.